List of Tables
Table 1. Global Diagnostic Nuclear Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Diagnostic Nuclear Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Diagnostic Nuclear Medicines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Diagnostic Nuclear Medicines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Diagnostic Nuclear Medicines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Diagnostic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Diagnostic Nuclear Medicines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Diagnostic Nuclear Medicines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Diagnostic Nuclear Medicines, Product Type & Application
Table 12. Global Key Manufacturers of Diagnostic Nuclear Medicines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Diagnostic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Medicines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Diagnostic Nuclear Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Diagnostic Nuclear Medicines Sales by Region (2019-2024) & (K Units)
Table 18. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2019-2024)
Table 19. Global Diagnostic Nuclear Medicines Sales by Region (2025-2030) & (K Units)
Table 20. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2025-2030)
Table 21. Global Diagnostic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2019-2024)
Table 23. Global Diagnostic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2025-2030)
Table 25. North America Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
Table 27. North America Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
Table 28. North America Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Diagnostic Nuclear Medicines Sales (K Units) by Type (2019-2024)
Table 51. Global Diagnostic Nuclear Medicines Sales (K Units) by Type (2025-2030)
Table 52. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2024)
Table 53. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2025-2030)
Table 54. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2024)
Table 57. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2025-2030)
Table 58. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Type (2019-2024)
Table 59. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Type (2025-2030)
Table 60. Global Diagnostic Nuclear Medicines Sales (K Units) by Application (2019-2024)
Table 61. Global Diagnostic Nuclear Medicines Sales (K Units) by Application (2025-2030)
Table 62. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2024)
Table 63. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2025-2030)
Table 64. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2024)
Table 67. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2025-2030)
Table 68. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Application (2019-2024)
Table 69. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Application (2025-2030)
Table 70. Cardinal Health Corporation Information
Table 71. Cardinal Health Description and Business Overview
Table 72. Cardinal Health Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Cardinal Health Diagnostic Nuclear Medicines Product
Table 74. Cardinal Health Recent Developments/Updates
Table 75. GE Healthcare Corporation Information
Table 76. GE Healthcare Description and Business Overview
Table 77. GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. GE Healthcare Diagnostic Nuclear Medicines Product
Table 79. GE Healthcare Recent Developments/Updates
Table 80. Curium Pharma Corporation Information
Table 81. Curium Pharma Description and Business Overview
Table 82. Curium Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Curium Pharma Diagnostic Nuclear Medicines Product
Table 84. Curium Pharma Recent Developments/Updates
Table 85. Jubilant Pharma Corporation Information
Table 86. Jubilant Pharma Description and Business Overview
Table 87. Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Jubilant Pharma Diagnostic Nuclear Medicines Product
Table 89. Jubilant Pharma Recent Developments/Updates
Table 90. Bracco Imaging Corporation Information
Table 91. Bracco Imaging Description and Business Overview
Table 92. Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Bracco Imaging Diagnostic Nuclear Medicines Product
Table 94. Bracco Imaging Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Novartis Diagnostic Nuclear Medicines Product
Table 99. Novartis Recent Developments/Updates
Table 100. SIEMENS Corporation Information
Table 101. SIEMENS Description and Business Overview
Table 102. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. SIEMENS Diagnostic Nuclear Medicines Product
Table 104. SIEMENS Recent Developments/Updates
Table 105. China Isotope & Radiation Corporation Information
Table 106. China Isotope & Radiation Description and Business Overview
Table 107. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. China Isotope & Radiation Diagnostic Nuclear Medicines Product
Table 109. China Isotope & Radiation Recent Developments/Updates
Table 110. Dongcheng Corporation Information
Table 111. Dongcheng Description and Business Overview
Table 112. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Dongcheng Diagnostic Nuclear Medicines Product
Table 114. Dongcheng Recent Developments/Updates
Table 115. Lantheus Corporation Information
Table 116. Lantheus Description and Business Overview
Table 117. Lantheus Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Lantheus Diagnostic Nuclear Medicines Product
Table 119. Lantheus Recent Developments/Updates
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Description and Business Overview
Table 122. Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Eli Lilly Diagnostic Nuclear Medicines Product
Table 124. Eli Lilly Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Diagnostic Nuclear Medicines Distributors List
Table 128. Diagnostic Nuclear Medicines Customers List
Table 129. Diagnostic Nuclear Medicines Market Trends
Table 130. Diagnostic Nuclear Medicines Market Drivers
Table 131. Diagnostic Nuclear Medicines Market Challenges
Table 132. Diagnostic Nuclear Medicines Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Diagnostic Nuclear Medicines
Figure 2. Global Diagnostic Nuclear Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Diagnostic Nuclear Medicines Market Share by Type in 2023 & 2030
Figure 4. Tc-99m Product Picture
Figure 5. F-18 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Diagnostic Nuclear Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Diagnostic Nuclear Medicines Market Share by Application in 2023 & 2030
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Global Diagnostic Nuclear Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Diagnostic Nuclear Medicines Market Size (2019-2030) & (US$ Million)
Figure 14. Global Diagnostic Nuclear Medicines Sales (2019-2030) & (K Units)
Figure 15. Global Diagnostic Nuclear Medicines Average Price (USD/Unit) & (2019-2030)
Figure 16. Diagnostic Nuclear Medicines Report Years Considered
Figure 17. Diagnostic Nuclear Medicines Sales Share by Manufacturers in 2023
Figure 18. Global Diagnostic Nuclear Medicines Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Diagnostic Nuclear Medicines Players: Market Share by Revenue in 2023
Figure 20. Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Diagnostic Nuclear Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Diagnostic Nuclear Medicines Sales Market Share by Country (2019-2030)
Figure 23. North America Diagnostic Nuclear Medicines Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Diagnostic Nuclear Medicines Sales Market Share by Country (2019-2030)
Figure 27. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country (2019-2030)
Figure 28. Germany Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Region (2019-2030)
Figure 35. China Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Diagnostic Nuclear Medicines Sales Market Share by Country (2019-2030)
Figure 46. Latin America Diagnostic Nuclear Medicines Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Diagnostic Nuclear Medicines Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Diagnostic Nuclear Medicines by Type (2019-2030)
Figure 56. Global Revenue Market Share of Diagnostic Nuclear Medicines by Type (2019-2030)
Figure 57. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Diagnostic Nuclear Medicines by Application (2019-2030)
Figure 59. Global Revenue Market Share of Diagnostic Nuclear Medicines by Application (2019-2030)
Figure 60. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Application (2019-2030)
Figure 61. Diagnostic Nuclear Medicines Value Chain
Figure 62. Diagnostic Nuclear Medicines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed